Dr. Michal Schnaider Beeri's lab at Rutgers focuses on understanding the complex roles of glycoproteins in Alzheimer's disease and related disorders. By studying the modifications on brain proteins, their work aims to identify new biomarkers and potential treatments that can help preserve cognitive and motor function in aging individuals. The lab utilizes advanced techniques and large datasets to explore how an active lifestyle may influence brain health through these glycoproteins.

Dr. Rafiq Huda's lab at Rutgers University is focused on understanding how the brain's arousal mechanisms interact with alcohol consumption behaviors. By studying the anterior cingulate cortex and its role in these interactions, the lab aims to uncover the neurobiological underpinnings of alcohol use disorders. Through advanced techniques like two-photon imaging and optogenetics, research conducted here seeks to develop new therapeutic strategies for treating alcohol abuse.

Kelvin Y. Kwan's lab at Rutgers University focuses on investigating the epigenetic factors that contribute to hearing loss, particularly through the study of the CHD4 protein in the cochlea. The team explores how alterations in CHD4 affect hair cell identity and function, with the goal of uncovering mechanisms for hair cell maintenance and potential regeneration. This research could lead to novel therapies for treating various forms of hearing impairment.